Loading
Addex Therapeutics Ltd Stock: price and insider trades · Switzerland
No insider purchase over the last 90 days. The latest was filed 27 Nov 2023.
Addex Therapeutics Ltd: what insiders have been doing
Headquartered in Plan-les-Ouates, Switzerland, Addex Therapeutics Ltd belongs to the Health Care sector and traces its origins to 2002. Filings by its managers are published through SIX SER. Addex Therapeutics Ltd has had no insider filing for more than a year; the last one goes back to 27 November 2023.
These figures are compiled from regulatory filings published by SIX SER. They describe what insiders did and are not a recommendation.
Key facts
Headquarters: Plan-les-Ouates, Switzerland · Founded: 2002
Source: Wikidata (CC0).
Insider Decl.
9
Thresholds
n/a
Buy Volume
€502,776
9 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CHF 0.04
Analyst consensus
Income statement
RevenueCHF 30k
EBITDA-CHF 6.8M-22794% margin
Net income-CHF 6.7M-22448.4% margin
Valuation
P/Book1.5x
Beta1.99
Balance sheet & cash
Market capCHF 6.2M
Total debtCHF 34.7k
Free Cash Flow-CHF 2.2M
Debt / Equity3%
Profitability & ownership
ROE-122.3%
ROA-23.6%
% insiders10.0%
% institutions1.0%
Last declaration on 27 November 2023
Declarations9 total
▲
Anonymous (Executive member of the board of directors / member of senior management)
1,250,224 shares@ CHF 0.04313.2% of flowISIN CH0029850754SIX:T1NBR000A6
Canonical exit: 25 Feb 2024 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
1,056,966 shares@ CHF 0.04311.1% of flowISIN CH0029850754SIX:T1NBR00098
Canonical exit: 25 Feb 2024 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
127,594 shares@ CHF 0.0431.3% of flowISIN CH0029850754SIX:T1NBR000B4
Canonical exit: 25 Feb 2024 (T+90)
91,323 shares@ CHF 0.0435.1% of flowISIN CH0029850754SIX:T1NBR000F5
Canonical exit: 25 Feb 2024 (T+90)
91,323 shares@ CHF 0.0435.1% of flowISIN CH0029850754SIX:T1NBR000E8
Canonical exit: 25 Feb 2024 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
50,000 shares@ CHF 0.0430.5% of flowISIN CH0029850754SIX:T1NBR000G3
Canonical exit: 25 Feb 2024 (T+90)
567,969 shares@ CHF 0.04331.7% of flowISIN CH0029850754SIX:T1NBR000D0
Canonical exit: 25 Feb 2024 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
7,008,033 shares@ CHF 0.04373.8% of flowISIN CH0029850754SIX:T1NBR00080
Canonical exit: 25 Feb 2024 (T+90)
1,043,153 shares@ CHF 0.04358.2% of flowISIN CH0029850754SIX:T1NBR000C2
Canonical exit: 25 Feb 2024 (T+90)
9 of 9 declarations
About Addex Therapeutics Ltd
Addex Therapeutics Ltd is a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. It is listed on the Swiss stock exchange XSWX.
